BioPharma Domination is Killing Manager Relative Performance

December 9, 2025

BioPharma Domination is Killing Manager Relative Performance

R2000 Sector QTD leadership is running extremely narrow – and most of the R2000’s gains are due to Health Care and BioPharma.  Only two sectors are beating the index QTD – this has never happened before in a full quarter.